S 1906
Promising Pathway Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Promising Pathway Act aims to expedite drug approval for serious or life-threatening diseases by establishing a ‘provisional approval’ pathway for certain drugs and biological products. The Food and Drug Administration (FDA) would review applications within 90 days and can approve them based on early evidence of efficacy and safety. Provisional approval lasts for up to eight years and requires ongoing data collection through patient registries, with potential penalties for non-compliance. The act also includes provisions for using real-world evidence and streamlining the review process, while ensuring transparency and patient involvement.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Mike Braun
Cosponsors
J. D. Vance
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.